With a growing understanding of the role of inflammation in CNS neurodegenerative disorders such as Alzheimer's disease (AD), neuroinflammatory disease has discovered distinct immune responses involving the adaptive and innate immune systems at different stages of disease. These responses could be used as therapeutic targets as well as driving disease processes. Immunotherapeutic techniques that have proven effective in Alzheimer's disease are increasingly being applied to other neurodegenerative diseases. The function of particular immune cell populations in the pathophysiology of neurodegenerative disorders has received more attention in recent years. Researchers in the discipline are working to understand the molecular pathways that underpin neurodegenerative diseases, which is one of the most important concerns of our era.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Him, that person and me
Simon C Barton, Stroke Survivor, United States
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States